AVR 0.38% $15.65 anteris technologies ltd

Ann: SAVR Clinical Trial, page-4

  1. 110 Posts.
    lightbulb Created with Sketch. 60
    We're up and running. I have never been more confident (after several years in this stock) that this is going to be big. I congratulate AHZ for restructuring the business to focus on this technology. IMHO, SAVR is much more tangible than the moon shot cure for herpes, or the grind of trying to sell patches in a crowded and dominated market. This time, the technology is proven and a world leader. And the company has millions available to it, including funds from the AHZOs.

    DYOR!
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.